News and Trends 23 Dec 2022
Merck and Kelun-Biotech collaborating on seven ADC cancer candidates
Merck (MSD outside of the U.S. and Canada), and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), have entered into an exclusive license and collaboration agreement to develop…
